Autoimmune pancreatitis (AIP) accounts for approximately 5% of chronic pancreatitis cases and is an important consideration in the differential diagnosis of pancreatic pathologies. The underlying pathophysiology of AIP is thought to involve lymphocyte infiltration and associated sclerosis. Although AIP is a benign condition that is treatable with corticosteroids, it can have imaging and clinical findings indistinguishable from pancreatic cancer. As such, the radiologist plays an important management role in distinguishing AIP from more sinister conditions. In addition, there are several extrapancreatic imaging findings in the context of AIP that have been recently described. This pictorial review outlines both the pancreatic and extrapancreatic imaging features in AIP and the response to steroid therapy. Important imaging features that allow AIP to be differentiated from other pancreatic pathology, including adenocarcinoma, lymphoma, and acute pancreatitis will be discussed.
Autoimmune pancreatitis (AIP) accounts for 4%e6% of chronic pancreatitis cases [1, 2] . AIP was initially described by Yoshida et al in 1995 [3] as a form of chronic pancreatitis with associated autoimmune manifestations. AIP is thought to involve systemic sclerosis related to IgG4 production [4, 5] . It is also now appreciated that there are several areas of extrapancreatic involvement in AIP including: kidneys, retroperitoneum, biliary system, prostate, and salivary glands [5, 6] . More recently, AIP has been classified as either type 1 or type 2 due to differences in histological patterns and clinical features. The more common type 1 AIP tends to affect older people (mean age 62 years), is associated elevated levels of IgG4-positive cells, histologically demonstrates a lymphoplasmacytic sclerosing pattern of pancreatitis and is associated with extrapancreatic manifestations [7e9]. Type 2 AIP tends to affect younger people (mean age 48 years) and is more difficult to diagnose due to a paucity of IgG4-positive cells and lack of extrapancreatic features. Type 2 AIP tends to be diagnosed at biopsy with pancreatic tissues demonstrating granulocytic epithelial lesions [7e9] .
A set of diagnostic criteria has been developed to differentiate autoimmune pancreatitis from other forms of chronic pancreatitis and pancreatic cancer [10] . Key distinguishing features include imaging demonstrating narrowing of the main pancreatic duct and enlargement of the pancreas, plus either laboratory findings (increased IgG or IgG4 or autoantibodies) or histopathologic evidence of interlobular fibrosis with lymphocyte and plasma cell infiltration [10] .
The clinical presentation of AIP depends on the type of pancreatic involvement (diffuse or focal) and the location of involvement (head, body, or tail of pancreas) [11] . Focal AIP involving the pancreatic head typically present with painless jaundice and weight loss, clinically mimicking pancreatic adenocarcinoma, whereas the focal forms in the pancreatic body and tail and the diffuse forms present with epigastric pain radiating to the back [11] . AIP is highly responsive to corticosteroid therapy [12] and distinction between AIP and other conditions is important in order to avoid unnecessary surgery or delayed treatment.
Pancreatic Findings
The diffuse or ''typical'' form of AIP accounts for 60% of cases. Here the pancreas appears diffusely enlarged or ''sausage-shaped'' on CT ( Figure 1A ) [13] . The pancreatic borders are featureless and there is effacement of the lobular contour [13] . A hypoattenuating capsule-like rim surrounding the pancreas is present in 12%e40% of cases ( Figure 1A ) [13] . Treatment with corticosteroids is associated with prompt improvement in symptoms and resolution of radiological appearances. After steroid treatment, pancreatic size returns to normal, the capsule-like rim disappears, and the pancreatic duct regains its normal caliber ( Figure 1B ) [12] . When the diagnosis of AIP is in doubt, a therapeutic trial of steroids or histology (obtained by endoscopic ultrasound guided biopsy or CT guided core Figure 1 . A contrast-enhanced computed tomography of a 65-year-old male with autoimmune pancreatitis. The pancreas is diffusely enlarged with a ''sausage'' type appearance with a surrounding hypoattenuating capsule-like rim (arrows) (A). One month after steroid treatment demonstrates that the pancreas (arrow) has re-acquired its normal morphology and the hypoattenuating capsule is no longer seen (B). [11] . b Depends on the injection rate: 3 mL/second, 45 and 70 seconds for parenchymal and venous phase respectively; 4 mL/second, 40 and 65 seconds for parenchymal and venous phase respectively; 5 mL/second, 35 and 60 seconds for parenchymal and venous phase respectively. Figure 2 . A 62-year-old man with autoimmune pancreatitis with diffuse pancreatic involvement. Axial transabdominal ultrasound shows a diffusely hypoechoic and enlarged pancreas. The biliary tree, kidneys, and prostate were also involved (not shown). biopsy) can be performed to confirm the diagnosis. A summary of the multidetector computed tomography (MDCT) pancreatic protocol and enhancement characteristic of normal pancreas, autoimmune pancreatitis and pancreatic carcinoma is listed in Table 1 . The diffusely enlarged pancreas and the capsule most commonly demonstrate a delayed enhancement pattern: decreased enhancement on computed tomography (CT) in the late arterial pancreatic parenchymal phase, and near normal enhancement in the portal venous phase of enhancement following intravenous contrast administration (with a 15 HU or greater increase from pancreatic to portal venous phase) [13, 14] . This is in contrast to normal pancreatic tissue, which demonstrates maximal enhancement in the late arterial phase [14] . On ultrasound, the pancreas appears diffusely enlarged and hypoechoic with compression of the main pancreatic by the parenchyma infiltrated parenchyma ( Figure 2 ) [15, 16] . A summary of the pancreatic magnetic resonance imaging (MRI) acquisition protocol is listed in Table 2 . On MRI, the diffusely enlarged gland appears hypointense on T1 and slightly hyperintense on T2 with heterogeneously diminished enhancement in the early phase of contrast enhancement and persistent enhancement on delayed imaging [13, 15] . Diffuse, pancreatic enlargement may also be seen with acute pancreatitis, lymphoma, and metastatic disease. Features favoring lymphoma include the presence of retroperitoneal and/or mesenteric lymphadenopathy, or an enlarged spleen. Conversely, the diagnosis of AIP should be favored over lymphoma when typical peri-or extrapancreatic findings are encountered. Differentiating features of AIP versus acute, non-necrotizing pancreatitis, would include the presence of retroperitoneal fluid, which is not seen in AIP. In addition, the aforementioned enhancement pattern of AIP differs from that seen in acute pancreatitis.
The focal or ''atypical'' form of AIP accounts for 40% of cases, and is associated with focal mass-like enlargement of a portion of the pancreas, typically the head and/or uncinate process. On CT, in the early arterial phase, the involved area is hypoattenuating compared to normal parenchyma making it indistinguishable from pancreatic adenocarcinoma ( Figure 3 , A and B) [14] . However, unlike pancreatic adenocarcinoma, which remains hypoattenuating on delayed CT imaging, AIP demonstrates delayed enhancement often becoming isointense to surrounding normal parenchyma. Another important distinguishing feature between focal AIP and pancreatic adenocarcinoma is the pattern of pancreatic duct dilatation. While the pancreatic duct within the lesion is not visible in either AIP or pancreatic adenocarcinoma, upstream main pancreatic duct dilatation (ie, >4 mm) is more often seen in adenocarcinoma (Figure 4 , AeF). In addition, abrupt cutoff in the duct suggests an adenocarcinoma [14] . In both focal and diffuse forms of AIP, pancreatic calcification is uncommon as are cysts and pseudocysts. MRI signal characteristics are similar to those of diffuse AIP.
Extrapancreatic Findings
The extrapancreatic manifestations are diverse and present simultaneously with pancreatic findings in 92% of cases [6] . They may also precede involvement of the pancreas or be delayed in onset following the initial diagnosis. Table 3 lists the distribution and prevalence of these findings. Familiarity with extrapancreatic findings can be helpful in establishing the diagnosis of AIP when the pancreatic findings alone are indeterminate. It is important to note that type 1 AIP is typically associated with extrapancreatic findings where type 2 does not [7e9]. Biliary tract involvement is the most common extrapancreatic site. It occurs in 88% of AIP cases and can occur in the absence of pancreatic findings [4] . The distal common bile duct is the most common site of involvement, but both intrahepatic and proximal extrahepatic duct involvement may occur [17, 18] . The clinical distinction between biliaryassociated AIP and primary sclerosing cholangitis (PSC) is an important one as PSC progresses, eventually leading to biliary cirrhosis. Medical therapy has not been proven delay the progression of PSC; however several options exist for symptom management. Ultimately, liver transplantation is the only curative option. In contrast, AIP-associated biliary changes are reversible with steroid treatment [12] . CT Figure 4 . A 61-year-old male with a focal mass in the pancreatic head. The mass (arrow) is hypointense on T2-weighted imaging (A) and mildly hypodense (arrow) on contrast-enhanced computed tomography (CT) (B). There was no associated dilatation of the main pancreatic duct (arrows) seen on both T2weighited imaging (C) or CT (D). Magnetic resonance cholangiopancreatography images obtained (E) redemonstrate the large mass in the pancreatic head (arrow) and endoscopic retrograde cholangiopancreatography (F) demonstrates marked narrowing of the common bile duct corresponding to the site of the mass (arrow). This patient underwent a Whipple's procedure and the mass was subsequently pathologically proven to be autoimmune pancreatitis. findings of biliary involvement in AIP include focal or diffuse biliary wall thickening, enhancement and dilatation ( Figure 5 ) [15, 16] . Endoscopic retrograde cholangiopancreatography can provide useful differentiating features. Nakazawa et al [17, 18] reported that band-like strictures, a beaded or pruned-tree appearance, and diverticulum-like formation were significantly more frequent in patients who had PSC. In contrast, segmental strictures, long strictures with prestenotic dilatation, and strictures of the distal common bile duct were more common in biliary AIP ( Figure 6 ) [17, 18] . Despite these differentiating features, AIP may still mimic primary sclerosing cholangitis and the presence of ancillary pancreatic and extrapancreatic findings can help to suggest the correct diagnosis. Gallbladder involvement is also commonly seen in AIP and is characterized by diffuse mural thickening [17, 18] . Lacrimal and salivary gland involvement occurs in 47.5% of patients with AIP [19] . The distribution of glandular involvement is listed in Table 3 . MRI shows bilateral homogenous swellings of the gland without a discernable mass [6, 19] . Unilateral involvement is much less common. Notably absent is the salt-and-pepper appearance, which describes the combination of punctate regions of calcification (pepper) and fatty replacement (salt), that is characteristic of Sjogren's syndrome [6] . The ultrasound appearance is not well described and we illustrate here (Figure 7, A and B ) a case of bilateral enlargement that is heterogeneous and contains multiple nodules. Biopsy of the swollen gland revealed abundant IgG4-bearing plasma cells in this patient with known AIP. Retroperitoneal involvement occurs in 20% of patients with AIP [6] . It appears as a rind-like accumulation of soft tissue surrounding the abdominal aorta and inferior vena cava, which may encase both ureters ( Figure 8A ) and extend along the retroperitoneal space into the pelvis. It may be difficult to distinguish AIP-associated para-aortic soft tissue infiltration from periaortitis in the presence of an abdominal aortic aneurysm. This would not be unexpected, however, as one type of inflammatory abdominal aortic aneurysm is IgG4-related [6] . Excellent response to steroid treatment can again be seen in AIP ( Figure 8B ).
Renal involvement in AIP is due to dense lymphocytic infiltration of the renal interstitium. Renal lesions vary from diffuse tubulointerstitial nephritis to tumour-like masses within the kidney [20] . Renal involvement is typically bilateral, with multiple poorly enhancing lesions ( Figure 9A ) [20] . Four morphological patterns have been described and include round lesions (either well or ill-defined), well-circumscribed wedged-shaped lesions, small peripheral cortical nodules, and diffuse patchy involvement [20] . The differential diagnosis of renal involvement includes multifocal pyelonephritis, renal infarction, renal lymphoma and metastatic disease. Ancillary pancreatic and extrapancreatic findings should suggest the diagnosis of AIP. Renal involvement responds well to steroid treatment ( Figure 9B ).
There are only a small number of reports describing IgG4associated prostatitis in AIP [21, 22] . However, none of them have illustrated the CT appearance. In one of the cases presented, the prostate appears diffusely enlarged and hypoattenuating with surrounding inflammatory stranding ( Figure 10 ). It may be difficult to distinguish prostatitis from prostate cancer and biopsy is often performed to confirm the diagnosis. A trial of steroids may also be useful in determining whether the findings are autoimmune in nature.
Furthermore, Fujinaga et al [6] described steroid responsive bilateral hilar lymphadenopathy (78% or patients) and nodular lesions, bronchial thickening, interlobular thickening, and consolidation (collectively seen in 54% of patients) when chest CT was preformed. Interestingly, the patients presented in this review did not have chest imaging prior to steroid treatment, which may be a reflection of local imaging practices directed at the site of clinical interest. The broad array of thoracic findings in IgG4-related diseases has been recently reviewed [23] .
The imaging findings of AIP are broad, affecting several organ systems. The pancreatic and extrapancreatic findings described in this review are summarized in Table 4 .
Conclusion
Two types of AIP have been described in the literature, with type 1 tending to display multisystemic involvement. The pancreatic and extrapancreatic findings in AIP can be mimickers of more serious pathology, including malignancy. It is important for the radiologist to be familiar with spectrum of imaging appearances in AIP so that an accurate diagnosis can lead to prompt treatment with steroids and avoidance of unnecessary surgery.
